كل ما تود معرفته عن pfizer

U.S. FDA, CDC See Early Signal of Possible Pfizer Bivalent COVID Shot Link to Stroke

A safety monitoring system flagged that U.S. drugmaker Pfizer Inc (PFE.N) and German partner BioNTech's updated COVID-19 shot could be linked to a type of brain stroke in older adults, according to…

15 January 2023

Paxlovid, Pfizer's anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken in Medford, Massachusetts, U.S., May 12, 2022. REUTERS/Brian Snyder/Illustration

U.S. Government to Test Pfizer's Paxlovid For Long COVID

The U.S. National Institutes of Health's $1 billion RECOVER Initiative has picked Pfizer Inc's (PFE.N) antiviral drug Paxlovid as the first treatment it will study in patients with long COVID,…

27 October 2022

Pfizer To Supply Up To 6 mln COVID Pill Courses For Lower Income Countries

Pfizer Inc (PFE.N) said it would supply up to 6 million courses of its COVID-19 antiviral treatment to NGO Global Fund for low- and middle-income countries that seek to address worldwide disparities…

23 September 2022

A healthcare worker prepares to administer a Pfizer/BioNTEch coronavirus disease (Covid-19) vaccine at The Michener Institute, in Toronto, Ontario on December 14, 2020. - Ontario, Canada's most populous province and one of the hardest hit by the pandemic, had 1,940 new cases and 23 deaths on Monday. The province is expected to give its next doses to nursing home workers as a priority, according to media reports. (Photo by CARLOS OSORIO / POOL / AFP) (Photo by CARLOS OSORIO/POOL/AFP via Getty Images)

Here’s Why the FDA Shouldn’t Rush Giving Full Approval to the COVID Vaccines

It’s undoubtedly a coincidence, but two commentators I find most thoughtful and trustworthy both weighed in Wednesday on the question of whether the Food and Drug Administration should just go ahead…

Michael Hiltzik 25 July 2021

Popular
Editor's Pick

Axel Rangel Garcia

Business & Economy

Test of wills: Iran’s ability to outlast the US blockade

26 April 2026

The standoff in the Hormuz is not simply a question of whether Tehran can survive economic pressure, but whether Washington can sustain the pressure at an acceptable cost.

Alex Vatanka

Al Majalla

Politics

Netanyahu's Iran victory claim falls on deaf ears in Israel

29 April 2026

Many Israelis actually believe that they lost the war, with opposition leader Yair Lapid accusing the Israeli premier of having led the country into "strategic collapse and diplomatic catastrophe"

Asaad Ghanem

Sara Padovan

Science & Technology

Iran’s 'mosquito fleet' presents a pesky problem

28 April 2026

The Strait of Hormuz is now poised to become the primary arena of confrontation, with Iran relying on speedboat-driven guerrilla warfare to confront the US navy.

Marco Mossad

A Syrian army soldier holds a national flag featuring Syria's President Bashar al-Assad in front of a building left in ruins on 5 June 2013 in the city of Qusayr in the Homs province.

AFP

Politics

Syria's taswiya slow roll creates a host of problems

28 April 2026

Former regime soldiers are stuck in limbo, as their undocumented status prevents them from working, travelling, and curbs family members' access to education, healthcare and social services

Haid Haid